A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

2,098

Participants

Timeline

Start Date

March 2, 2006

Primary Completion Date

July 7, 2014

Study Completion Date

January 31, 2017

Conditions
Breast CancerNeoplasm Metastasis
Interventions
OTHER

Standard supportive care (packed RBC transfusion)

Per doctor prescription

DRUG

epoetin alfa + packed RBC transfusion

40,000 IU SC once a week.

Trial Locations (174)

Unknown

Anaheim

Gainesville

Miami

New Port Richey

Rockledge

Hazard

Alexandria

Marrero

Jackson

Lake Success

Staten Island

Philadelphia

Corpus Christi

Houston

Buenos Aires

Capital Federal

Ciudad Autonoma de Buenos Airess

Córdoba

La Plata

Mendoza

Quilmes

Rosario

Santa Fe

Barretos

Curitiba

Goiânia/Go

Ijuí

Jaú

Piracicaba

Porto Alegre

Ribeirão Preto/Sp

Santo André

São José do Rio Preto

São Paulo

São Paulol

Plovdiv

Rousse

Sofia

Stara Zagora

Varna

Arica

Santiago

Temuco

Valdivia

Valparaíso

Bogotá

Floridablanca-Santander

Montería

Cuenca

Guayaquil

Portoviejo

Quito

Batumi

Tbilisi

New Territories

Ahmedabad

Andra Pradesh

Bangalore

Bengaluru

Bhopal

Delhi

Hyderabad

Jaipur

Kārnād

Kerala

Kochi

Kolkata

Mangalore

Mumbai

Nashik

New Delhi

Pune

Tamil Nadu Na

Tamil Nadu

Thiruvananthapuram

Uttar Pradesh

Vellore

Bandung

Jakarta

Semarang

Yogyakarta

George Town

Kampung Baharu Nilai

Kelantan

Kuala Lumpur

Tanjung Bungah

Chihuahua City

Guerrero

León

Mérida

Morelia

Puebla City

San Luis Potosí City

Sinaloa

Zapopan

Bitola

Skopje

Cebu

Davao City

Iloilo City

Manila

Quezon City

Bialystok

Gdansk

Gliwice

Katowice

Krakow

Lodz

Olsztyn

Poznan

Wroclaw

Brasov

Bucharest

Cluj-Napoca

Iași

Onești

Sibiu

Suceava

Timișoara

Arkhangelsk

Balashikha

Belgorod

Chelyabinsk

Engels Saratov Region

Ivanovo

Kazan'

Krasnodar

Leningrad Region

Lipetsk

Magnitogorsk

Moscow

Novosibirsk

Obninsk

Orenburg

Perm

Pyatigorsk

Ryazan

Saint Petersburg

Smolensk

Tyumen

Ufa

Voronezh

Yekaterinburg

Bloemfontein

Cape Town

Durban

Johannesburg

Klerksdorp

Port Elizabeth

Pretoria

Changhua

Chiayi City

Hualien City

Kaohsiung City

Taichung

Tainan City

Taipei

Taoyuan District

Cherkassy

Chernihiv

Chernivtsi

Dnipro

Donetsk

Ivano-Francovsk

Kharkiv

Kiev

Lviv

Odesa

Poltava

Sumy

Uzhhorod

Vinnitsa

Vinnytsia

Zaporizhzhya

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT00338286 - A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy | Biotech Hunter | Biotech Hunter